InvestorsHub Logo
Followers 62
Posts 3932
Boards Moderated 0
Alias Born 12/21/2010

Re: dr_lowenstein post# 177539

Thursday, 01/07/2016 3:42:02 AM

Thursday, January 07, 2016 3:42:02 AM

Post# of 403224
Quote:
------
Purdue slated to appear before the FDA's panel of analgesic experts to go over whether its new formulation of the oxycodone drug is successfully deterring abuse. But Purdue has since backed out of that meeting and canceled its supplemental application altogether
-------

Doesent sound good imo
Should have looked at elite and said YES YES YES
But they choose to give it their own shot while they let elite do it their way
Smart move from purdue
Never put all your eggs in one basket
They dont care , they have the money,And now they failed they can always buys elites tech after approval
Does $8 sounds good?
Or when there is comptition to get the tech $10 or $14 ? ?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News